Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefdinir Granules

Approval Number

国药准字H20244249

Company齐鲁安替制药有限公司

Registration Date

June 28, 2024

Drug Information

Generic Name

头孢地尼颗粒

Dosage Form

颗粒剂

Strength

50mg

Drug Type

化学药品

Registration Date

June 28, 2024

Company Information

Applicant Company

Company Name齐鲁安替制药有限公司

Company Address

山东省济南市历城区董家街道849号

Manufacturing Company

Company Name齐鲁安替制药有限公司

Company Address

山东省济南市历城区董家街道849号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

头孢地尼颗粒 - NMPA 批准文号 | MedPath